Health, Education & Government Life Sciences & Pharma Diagnostic Equipment

Pathology Systems

Regulated development and commercialization journeys where clinical, quality, and market access align.

Example organizations in this space: Leica Biosystems (Danaher) Hamamatsu Roche Diagnostics Philips

This interactive experience is the shipped product itself — the same application code customers run in production, mounted read-only in your browser over a real sample journey. Not a video, not a mockup: because the demo and the product are one codebase, it can never drift from the real thing.

Inside this journey
  1. Clinical Outcome Discovery

    Align on diagnostic goals, current pathology workflows, headcount constraints, and measurable success signals for digital pathology adoption.

    Discovery Questions

    Mapping Your Daily Diagnostic Flow

    • On a typical weekday, walk me through how a case moves from grossing to sign-out in your lab.
    • Which roles touch the glass slides and digital images at each step? Options: Grossing technicians, Histology technicians, Slide scanner operators, Pathologists (attendings), Residents and fellows, Cytotechnologists, Laboratory managers, IT support, Other
    • Approximately how many glass slides and unique diagnostic cases does your department generate per typical day? Options: Under 100 slides / under 25 cases, 100–500 slides / 25–125 cases, 500–1,500 slides / 125–350 cases, Over 1,500 slides / over 350 cases
    • How often does a case require off-site consult or subspecialty input today? Options: Multiple times per day, A few times per week, A few times per month, Rarely, Never
    • Is there any campus, laboratory, or subspecialty where remote sign-out or primary-digital diagnosis is currently prohibited? Options: Yes, No
    • When prohibitions apply, list the campuses, services, or policies that prevent remote sign-out and describe the reason (regulatory, clinical leadership, contractual, other).

    Where Workflows Fray Under Pressure

    • If slide volume increased 20% tomorrow, identify which part of your workflow would fail first and why.
    • Walk me through the last time a scanner backlog or transport delay impacted patient care, who raised the issue, and what the consequence was.
    • Choose up to three steps that most often create bottlenecks for turnaround time. Options: Specimen accessioning and labeling, Grossing and tissue processing, Slide staining and coverslipping, Slide scanning queue, Viewer performance at sign-out, Pathologist availability for review, Case routing and consults, LIS case linking
    • Estimate the average time from slide completion to first pathologist review for routine surgical pathology cases. Options: Under 24 hours, 24–48 hours, 48–72 hours, Over 72 hours
    • What downstream functions break when scanners fall behind on a high-volume day, for example tumor boards, frozen sections, or consult turnaround?
    • Name the one bottleneck that, if removed, would shorten your overall turnaround enough to change clinical decisions.

    The Real Cost of Staying Microscope-First

    • If you keep a microscope-first model for three more years, identify the concrete costs you expect to accumulate in staffing, transport, or lost revenue.
    • Provide a recent example where intra-system slide transport or access limitations caused a clinically significant delay or repeat testing.
    • How many open pathologist FTEs do you currently have, and how long have those positions remained vacant on average? Options: No vacancies, 1–2 FTEs, under 6 months, 1–3 FTEs, 6–12 months, Multiple vacancies, over 12 months
    • Point to the recurring expense that surprises executive leadership the most when you break down the pathology budget.
    • Would your leadership approve capital or operating funds for a digital pathology investment that only returns parity after five years? Options: Yes, with conditions, Yes, unconditionally, No, Undecided

    What's Getting in the Way of Digital Adoption

    • Identify the regulatory, clinical validation, or policy barrier most likely to stop this project before pilot completion.
    • Tell me about prior attempts to change diagnostic workflows here, how pathologists responded, and which actions helped or hindered adoption.
    • Does your institution require a formal clinical validation protocol and written sign-off before enabling primary-diagnostic use of new imaging systems? Options: Yes, strict protocol required, Yes, but flexible, No formal protocol, Unsure
    • List the top three technical concerns your IT or data governance teams raise about storing and serving whole slide images.
    • Select up to two vendor capabilities that you believe would most reduce clinician resistance to digital sign-out. Options: High-fidelity viewer matching microscope field of view, Validated image quality and concordance studies, Integrated AI assistants with clear clinical controls, Familiar user interface for pathologists, On-site validation and training support, Clear regulatory documentation
    • Confirm whether any institutional policy, accreditation, or legal constraint would prevent you from piloting AI-assisted diagnostic tools. Options: Yes, No, Under review

    Who Else Is Trying to Solve This

    • Who else are you actively evaluating for digital pathology options, including internal teams and outside vendors? Options: Current incumbent vendor, Other external vendors, Internal IT or informatics team, Point-solution scanner vendors only, Open-source tools, No alternatives under evaluation
    • Choose the approaches you are most likely to pursue, select any that apply. Options: Renew with incumbent, Run an external vendor pilot, Build an in-house image management solution, Adopt a hybrid model (scanners + hosted viewer), Delay decision
    • Describe the evidence or performance improvements that would have to exist for you to keep the current approach instead of moving to a new system.
    • Has anyone on your leadership team formally proposed solving scanning or image management internally rather than partnering with an outside vendor? Options: Yes, formal proposal exists, Yes, informal discussion only, No
    • Could your team still prefer an internal solution even after an external pilot demonstrates equivalent diagnostic performance? Why or why not?
    • If the pilot proves diagnostic parity, which contractual or organizational issue would most likely delay a purchase decision? Options: Budget timing, Procurement rules, Regulatory sign-off, Internal preference for internal build, Other

    Can This Be Deployed Where You Need It

    • Identify the single integration or infrastructure gap that would stop deployment before day one.
    • List the laboratory information systems, middleware, and reporting systems that must exchange orders and results with the image management platform.
    • Do APIs or HL7 interfaces already exist for those systems, and who in IT is the point owner for each? Options: APIs exist, owners named, APIs partially available, owners unclear, No APIs, owners not assigned, Unsure
    • Estimate the number of IT FTEs you can allocate to integrations and validation work over the next 90 days. Options: 0 FTEs, 0.5–1 FTE, 1–3 FTEs, Over 3 FTEs
    • Where will slide scanning physically occur and do those rooms meet climate, power, and network requirements today? Options: All sites ready, Some sites need upgrades, No sites ready, Unsure
    • Are there documented data retention policies, storage tiering rules, or archival limits that will constrain whole slide image retention? Options: Yes, strict retention and tiers, Yes, flexible retention, No formal policy, Unsure
    • Confirm whether named clinical leadership is prepared to own per-site validation, acceptance testing, and final sign-off before go-live. Options: Yes, named owners ready, Partial commitment, owners not named, No, leadership not committed, Unsure

    Pilot Success and Acceptance

    • Describe your fallback plan if the pilot cannot meet your image quality or diagnostic concordance thresholds.
    • Select the objective acceptance criteria that matter most for pilot success, pick up to five. Options: Diagnostic concordance vs glass (target %), Average scanner throughput (slides per hour), Viewer responsiveness under load, Successful LIS order/result integration, Pathologist satisfaction scores, AI sensitivity and specificity targets, No critical safety incidents
    • Who on your clinical and operational team must sign the pilot acceptance, and what evidence will satisfy each signer?
    • Explain how you will measure AI tool performance during the pilot and which case types or subspecialties you will include.
    • Provide the quantitative image quality thresholds, for example minimum resolution, color fidelity standards, or allowable artifact rates, that would cause you to stop the pilot.
    • Assuming the pilot meets every stated acceptance criterion, can your procurement team commit to a purchase intent or PO within 30 days? Options: Yes, No, Maybe, needs conditions

    Decision Timing and Next Steps

    • What single timing or budget issue could collapse your timeline and force an accelerated go/no-go decision?
    • Provide the stakeholders, committees, and their review cadence that must approve this project before contract execution.
    • Choose your target go-live window for primary-diagnostic use across the initial sites. Options: Next quarter (0–3 months), In two quarters (3–6 months), This year (6–12 months), Longer than 12 months, Unsure
    • Name the individual who controls budget approval and the person who will sign the final purchase order.
    • Assuming budget approval this quarter, are you able to start a pilot within 4 weeks? Options: Yes, No, Only with prerequisite approvals
    • Point out the one answer on this form that would cause you to stop the project immediately.
  2. Solution Walkthrough

    Translate outcomes into realistic clinical workflows by walking through scanning, viewer, AI-integration, and remote consult scenarios with stakeholder priorities.

    Solution Experience

    • Solution Experience: Clinical Workflow Walkthrough
    • Confirm the current state and its cost
    • You confirm the demonstrated scanning workflow meets your required throughput and QC to prevent backlog and overtime.
    • Run a site-specific scanner throughput simulation using the provided weekly slide volumes and deliver the results before the pilot planning meeting.
    • You confirm the viewer workflow supports diagnostic parity for the subspecialties you prioritized.
    • Prove the scanning throughput and quality workflow
    • Produce a draft pilot validation plan that lists measurable acceptance criteria, test cases, timelines, and required clinical evidence.
    • You confirm the AI triage scenario produces the expected reduction in manual review and is acceptable within your validation constraints.
    • Provide per-site weekly slide volumes by case type, peak scanner-hours, and current consult turnaround metrics.
    • Prove the diagnostic viewer workflow for primary sign-out
    • You agree on specific pilot acceptance criteria, required evidence, and named owners for the pilot phase.
    • Prove AI triage and integration in a realistic case flow
    • Identify the named clinical owner(s) and the IT owner who will sign off on pilot acceptance per site.
    • Confirm pilot site list and a target two-week window for pilot kickoff.
    • Prove the remote consult handoff and collaboration flow
    • Validation check, confirm this matches your needs
    • Agree pilot acceptance gates and next evidence steps
    • Solution Experience: Clinical Workflow Walkthrough
    • Solution Experience Deck
    • Solution Brief
    • meeting
    • slides
    • document
  3. Solution Scope

    Define scanners, storage architecture, viewer and integration modules, validation responsibilities, training, and phased adoption milestones.

    Scope Configuration

    • Install and Commission Whole Slide Scanners
    • Calibrate Scanners and Establish QC Protocols
    • Bulk Slide Digitization (Backlog Scanning)
    • Deploy Enterprise Image Management Platform
    • Integrate Image Platform with LIS/EMR
    • Configure Diagnostic Viewer and Annotation Tools
    • Enable Remote Consultation and Case Collaboration
    • Integrate and Deploy AI-Assisted Analysis Tools
    • Scanner and Workflow Validation for Primary Diagnosis
    • Provision Enterprise Image Storage and Archive
    • Configure Backup, Replication and Disaster Recovery
    • Train Pathologists on Digital Diagnostic Workflows
    • Train Laboratory Technicians on Scanning Operations
    • Provide Equipment Financing and Incentive Qualification

    Scope Questions

    Install and Commission Whole Slide Scanners

    • List the physical locations (building and room numbers) and available install windows for scanner delivery and on-site commissioning.
    • How many scanners do you plan to install at each site? Options: 1, 2-3, 4-6, 7+
    • Provide target throughput per scanner expressed as slides per hour at 40x for routine H&E cases. Options: <100, 100-300, 301-600, 600+
    • Identify the slide and specimen types to be scanned routinely (H&E, immunohistochemistry, special stains, cytology, frozen sections). Options: H&E, Immunohistochemistry (IHC), Special stains, Cytology, Frozen sections
    • Specify required WSI output formats and any naming convention rules your archive or downstream tools expect. Options: OME-TIFF, DICOM WSI, Proprietary vendor WSI, Other
    • Who will be the on-site owner for commissioning activities and who provides building access and electrical/IT contact?

    Calibrate Scanners and Establish QC Protocols

    • Describe the calibration targets and reference tissue slides you will supply for optical and color calibration (e.g., color chart, tissue control).
    • State the required frequency for optical calibration and white-balance checks for each scanner. Options: Per shift, Daily, Weekly, Monthly, Other
    • List the quality-control (QC) metrics you require recorded per scanned batch (for example: focus score, resolution, color balance, z-plane completeness).
    • Name the role responsible for QC triage and remediation when a slide fails automated QC.
    • Are automated QC rejection workflows required to prevent failed WSIs from ingesting into the archive? Options: Yes, No
    • Specify the required audit-log retention period for QC events and calibration records. Options: 30 days, 90 days, 1 year, Custom

    Bulk Slide Digitization (Backlog Scanning)

    • Estimate backlog volume in number of glass slides and your preferred completion timeline for backlog digitization.
    • Indicate the stain-mix composition of the backlog by percentage (H&E, IHC, special stains, cytology). Options: H&E, IHC, Special stains, Cytology
    • Explain how accession identifiers on glass slides must be preserved or mapped to resulting WSI filenames to match your LIS records.
    • Select the barcode symbology used for slide tracking in your lab. Options: Code 128, DataMatrix, QR, Custom label, No barcode
    • Describe chain-of-custody and interim storage requirements during bulk scanning and transport between stations.
    • Choose the backlog QC sampling strategy you require for acceptance. Options: 100% visual check, 10% random sample, 5% random sample, Custom

    Deploy Enterprise Image Management Platform

    • Select your preferred deployment model for the image management platform. Options: On-premises, Cloud-hosted, Hybrid
    • Name the laboratory information system (LIS) and electronic medical record (EMR) products that the platform must integrate with.
    • Identify required authentication methods for clinician access (for example LDAP/Active Directory, SAML single sign-on). Options: LDAP/Active Directory, SAML single sign-on, Local accounts, Other
    • Provide expected concurrent pathologist sessions and peak case-load numbers the platform must support. Options: <10, 10-50, 51-200, 200+
    • What evidence will validate platform integration with your LIS (for example HL7 message traces, successful order-pull and result-posting test cases)?
    • List metadata fields required for indexing each case (accession number, slide ID, stain, magnification, barcode).

    Integrate Image Platform with LIS/EMR

    • Enumerate the HL7 message types and triggers required between the platform and your LIS (for example ORM order, ORU results, ADT updates).
    • Provide available API endpoints or FHIR resources your IT team can provide for metadata exchange or document references.
    • Describe required field mappings between LIS accession fields (case ID, patient MRN, specimen container) and image-platform metadata.
    • Identify your LIS/EMR technical contact for interface testing and their preferred hours for integration work.
    • Describe the test data set and sandbox access you will provide for end-to-end interface validation.
    • Will patient-identifiers or MRN formats require transformation or mapping during integration? Options: Yes, No

    Configure Diagnostic Viewer and Annotation Tools

    • List the annotation and measurement tools your pathologists require in the viewer (for example caliper, polygon ROI, cell counter, bookmarks).
    • Provide the acceptable first-image-load time over your WAN for a 40x WSI used in primary sign-out. Options: <2s, 2-5s, 5-15s, 15+s
    • State required stain-normalization or color-profile options (for example ICC profiles or stain-vector normalization) for consistent display across sites.
    • Describe multi-monitor or synchronized-slide behaviors needed for shared sign-out or multi-site review.
    • Who will approve viewer UI presets and workflow defaults for primary diagnosis?
    • Will you require audit logs for viewer annotations, report edits, and sign-out events? Options: Yes, No

    Enable Remote Consultation and Case Collaboration

    • Select the remote consultation modes you plan to use. Options: Asynchronous consult (shared WSI link), Live case sharing (real-time session), Screen-share sign-out, Other
    • Provide your target turnaround SLA for remote consults (in hours or business days). Options: <1 hour, 1-4 hours, Same day, 48 hours, Custom
    • Specify the expected number of external consulting pathologists and the access privileges they require.
    • Describe secure-sharing and data-embargo policies that apply when WSIs are shared outside your firewall.
    • Indicate concurrence, co-signoff or consult-to-sign workflows required for consult cases.
    • List any regional data residency or HIPAA-related constraints that affect cross-site consultation.

    Integrate and Deploy AI-Assisted Analysis Tools

    • Enumerate AI use cases you want in scope (for example tumor detection, IHC quantification, mitotic count, tissue segmentation).
    • Specify required model input and output formats and overlays (for example WSI tiles, JSON overlays, DICOM structured report).
    • Provide target performance thresholds for each AI model you plan to deploy (for example sensitivity >= 90% for tumor detection).
    • Describe available institutional validation datasets for benchmarking (number of annotated slides and cases by stain and subspecialty).
    • Identify who will own clinical validation, regulatory traceability, and documentation for AI outputs.
    • Select preferred runtime location for AI inference. Options: On-premises, Edge appliance (near scanner), Cloud-hosted, Hybrid

    Scanner and Workflow Validation for Primary Diagnosis

    • List the clinical subspecialties you intend to validate for primary diagnosis during the pilot (for example GI, dermatopathology, GU).
    • Choose the concordance study design you prefer for primary-diagnosis validation. Options: Prospective side-by-side, Retrospective blinded, Hybrid
    • Provide the number of cases per subspecialty and the number of pathologists required to achieve statistically meaningful concordance.
    • What measurable acceptance criteria will confirm diagnostic equivalence for primary diagnosis (for example concordance rate >= 95%, minimum image resolution metrics)?
    • Name the clinical sign-off owners required for per-site validation and final acceptance.
    • Specify the validation artifacts that must be archived for regulatory audit (validation protocol, case discrepancy logs, signed run sheets).

    Provision Enterprise Image Storage and Archive

    • Estimate average WSI file size at 20x and 40x for H&E and for typical IHC slides (MB or GB per slide).
    • Provide total active and nearline storage capacity needs for Year 1 and Year 5.
    • What retention periods and retrieval SLAs will confirm storage readiness (for example 7-year retention, retrieval latency < 10s for a 20x WSI)?
    • Select storage access protocols required by your environment. Options: S3-compatible object, NFS, SMB, Other
    • Indicate whether eDiscovery and legal-hold workflows are required for pathology cases. Options: Yes, No
    • Specify required encryption and transport standards for data at rest and in transit. Options: AES-256, TLS 1.2+, FIPS-validated modules, Other
  4. Clinical Evaluation & Pilot

    Run a site pilot to validate image quality, viewer usability, scanner throughput, AI performance, and acceptance criteria in the buyer's clinical environment.

    • current_state
    • decision_readiness
    • stakeholders
    • gaps
    • desired_state
    • success_criteria
    • desired_state
    • success_criteria
    • gaps
    • current_state
    • decision_readiness
    • stakeholders
    • stakeholders
    • decision_readiness
    • current_state
    • desired_state
    • success_criteria
    • gaps
    • decision_readiness
    • decision_readiness
    • decision_readiness
    • decision_readiness
  5. Mutual Commit

    Finalize commercial and legal terms, acceptance gates, timelines, and responsibilities including regulatory and validation obligations.

    Agreement Modules

    • Master Services Agreement (MSA)
    • Statement of Work (SOW)
    • Hardware Purchase Agreement
    • Software Subscription Order Form
    • Service Level Agreement (SLA) & Support Addendum
    • Data Processing Agreement / HIPAA Business Associate Addendum (BAA)
    • Acceptance & Validation Criteria
    • Regulatory & Validation Responsibilities Schedule
    • Training & Knowledge Transfer Agreement
    • Payment Schedule & Order Confirmation
    • Change Order Agreement
    • Termination & Transition Assistance
    • Confidentiality Agreement
  6. Deployment

    Operationalize rollout with readiness checks, execution, and outcome validation.

    1. Pre-Deployment Readiness

      Confirm concrete readiness facts — facility access, LIS integration points, storage sizing, data retention policy, and named owners for each site.

      Pre-Deployment Questions

      Environment and site access

      • Is this a single-site rollout or a multi-site rollout? (We schedule installs per site and will require per-site readiness facts.) Options: Single site, Multi-site
      • Earliest available installation date per site (provide site name and earliest install window). This lets the deployment team book field engineers and shipments.
      • Are physical site requirements confirmed for each site (scanner bench space, power availability, network drop on the install day)? (Select the best match.) Options: Yes — all sites meet requirements, Partially — some sites need prep (list below), No — site prep required

      Data and configuration readiness

      • Is the buyer's LIS environment identified for integration (production vs. test/staging) so we can plan mapping and test schedules? Options: Production org identified, Only test/staging identified, Not identified yet
      • Has ownership of field mapping and data governance been assigned (who will approve mappings and be the source-of-truth for patient/case fields)? Options: Buyer owns mapping and approvals, Seller performs mapping with buyer sign-off, Third party owns mapping, Not assigned yet
      • Has storage sizing and the data retention policy been approved for each site (retention period, archival tiering, cloud vs. on-prem intent)? (We need confirmation, not the size values.) Options: Yes — retention and sizing approach finalized, Sizing done but retention policy under review, No — need decisions / assistance

      People and ownership (per site)

      • Provide the named owner(s) per site for these workstreams: site access/logistics, IT/network/storage, LIS/integration, and clinical acceptance (format: Site — Role: Name, Email).
      • Who has final go-live sign-off at each site (role and name — e.g., lab director, pathology chair)? This determines final acceptance responsibility.

      Timing, constraints, and approvals

      • Are there regulatory, validation, or operational blackout periods or milestone gates that block installations or go-live at any site? (If yes, list dates/milestones so we can avoid them.) Options: No, Yes — dates/milestones to follow
      • Which IT or procurement constraints will materially affect provisioning timelines (select all that apply)? Examples: firewall change windows, storage hardware procurement, cloud approval, change-management lead time. Options: Firewall changes / firewall change window, Storage hardware procurement lead time, Cloud provisioning/approval, Change-management / CAB approval lead time, No known constraints, Other — will describe
    2. Integration & Configuration

      Lock exact configuration values the deployment team will use — API endpoints, credentials, field mappings, scanner settings, and storage provisioning.

      Configuration Details

      ENVIRONMENTS & ENDPOINTS

      • Enter your production image-management API base URL (format: https://<hostname>[:port]/api). This exact value will be used by the deployment build.
      • Primary storage deployment type (select one) — used to drive storage provisioning and deployment steps. Options: Cloud object storage (S3-compatible), On-premise NAS (NFS/SMB), Hybrid (cloud + on-prem), Local appliance provided by the seller

      AUTHENTICATION & INTEGRATION ACCOUNTS

      • Which identity provider (IdP) type will your pathologists use for SSO? Select one. Options: SAML-based IdP, OIDC-based IdP, LDAP / Active Directory (LDAPS), No SSO — local accounts only
      • Enter your identity provider metadata URL (format: https://<idp-metadata>) or your LDAP bind DN (format: cn=binduser,dc=example,dc=com). If No SSO, enter 'N/A'.
      • Enter the non-secret integration API account username that the platform will call as (format example: service-imaging@yourorg). Do NOT paste a password or token — the secret will be exchanged via your secrets manager at kickoff.
      • Enter the named owner of the integration credential and the secure channel for secret exchange in this exact format: "Full Name <[email protected]> | secure-channel" (secure-channel examples: 'Your secrets manager', 'SFTP to admin', 'Manual exchange at kickoff'). If TBD, enter 'TBD'.

      LIS INTEGRATION & FIELD MAPPINGS

      • LIS integration method for pushing/pulling cases to the platform (select one). Options: HL7 v2 (ORM/ORU), REST API (push/pull), SFTP file drops (CSV or JSON), No LIS integration for deployment
      • Enter the exact LIS field name that will map to the platform's primary case identifier (examples: ACCESSION_NUMBER, ACC_NO). Use the exact field/key name as it appears in your LIS messages.

      SCANNING, IMAGE SETTINGS & RETENTION

      • Default scanning magnification to use for most diagnostic cases (select one). Default is 20x. Options: 20x (default), 40x, Both (will be set per-protocol)
      • Primary image retention period in days (numeric). Default is 3650 (10 years) — confirm or specify another value.
    3. Deployment & Site Rollout

      Execute scanner installs, validation runs, LIS integrations, training, and phased handovers with clear owners and milestone tracking.

    4. Go-Live Validation

      Formal per-site acceptance checklist verifying diagnostic equivalence, regulatory requirements, and sign-off from named clinical owners before primary-diagnosis use.

      Checklist items

      • Receive per-site validation report signed by the designated clinical owner
      • Complete diagnostic equivalence case set with pass/fail results
      • Confirm image quality checklist passed for each installed scanner
      • Finalize viewer usability and annotation UAT with clinical user sign-off
      • Verify end-to-end LIS/information-flow tests passed
      • Validate storage, backup, and retention configuration and perform restore test
      • Execute and document rollback/disaster-recovery plan with tested restore
      • Confirm regulatory and site validation artifacts are complete and signed
      • Obtain completed training records and acknowledged clinical responsibilities from named clinical owners
      • Verify monitoring, alerting, and incident-escalation contacts and runbook are in place
      • Record formal go/no-go decision and enable primary-diagnosis mode
  7. Post-Launch Success

    Monitor adoption, diagnostic KPIs, issue tracking, and prioritized enhancements while running recurring outcome reviews with stakeholders.

    Success Reviews

    • Go-live Health Check (weeks 1-4)
    • First Measurement Review (weeks 4-10)
    • 90-day Realization Review
    • Monthly Operational Check-in (recurring)
    • Quarterly Outcomes Review (executive)
    • Annual Outcomes and Capacity Review

    Issues & Enhancements

    • Agree the prioritized enhancement list for the next quarter with delivery timelines.
    • Ensure operational KPIs remain within agreed thresholds or have active remediation plans.
    • Reduce the count of critical unresolved tickets and document action owners and dates for remaining items.
    • Agree next month's operational priorities and any required configuration changes to maintain throughput.
    • Deliver the updated operational KPI extract and ticket status report before the next monthly check-in.
    • Implement the agreed configuration change or patch in the test environment and report test results.
    • Archive resolved incident records and update the incident review log for regulatory traceability.
    • Executive KPI summary
    • Confirm whether adoption and AI concordance are meeting executive expectations or require program-level adjustments.
    • Re-confirm success criteria and owners
    • Ensure regulatory and validation obligations are on track and assign any outstanding documentation tasks.
    • Publish the quarterly outcomes dashboard with annotated trends and risk items.
    • Deliver a prioritized enhancement plan with acceptance criteria for the next quarter.
    • Compile and share validation evidence packages required for upcoming audits.
    • Yearly trend analysis
    • Validate whether long-term diagnostic turnaround and storage growth are within acceptable bounds or require strategic remediation.
    • Ensure data retention and archival processes meet regulatory requirements and retrieval SLAs.
    • Agree on capacity adjustments or storage tiering actions to cover the next 12 months.
    • Produce the annual outcomes dossier including supporting logs and audit evidence for retention compliance.
    • Publish the 12-month capacity plan with procurement or tiering recommendations.
    • Schedule any required large-scale validation exercises for major configuration or storage changes.
    • Confirm all planned per-site deployment tasks are complete or have a documented remediation plan with owners and dates.
    • Identify the top three operational blockers that would prevent meaningful KPI measurement and agree remediation steps.
    • Schedule the First Measurement Review with the data sources and owners identified.
    • Publish a Go-live validation summary including outstanding defects and owners.
    • Collect and share the data extract for the First Measurement meeting from the image management and LIS logs.
    • Implement short-term mitigations for any critical integration failures and report status before the next meeting.
    • Present first-cycle KPI data
    • Decide whether weekly active pathologists using the viewer and diagnostic turnaround time for primary cases are on acceptable trajectories or require intervention.
    • Produce a timebound remediation plan for each KPI gap with clear deliverables and dates.
    • Confirm the data sources and cadence for ongoing KPI reporting.
    • Deliver the cleaned KPI dataset and visualization for the 90-day Realization Review.
    • Implement agreed scanner configuration or workflow adjustments that address identified bottlenecks.
    • Close or reclassify low-priority tickets that do not affect KPI trajectories.
    • Outcomes summary versus targets
    • Agree final disposition for each outstanding remediation item with deadlines that close the onboarding window.
    • Confirm the incumbent system is either decommissioned or formally retained read-only with documented data archiving and access controls.
    • Validate clinician proficiency levels and commit to any final training required to sustain outcomes.
    • Publish the 90-day realization report showing metric trajectories and remediation status.
    • Execute the incumbent decommission or read-only retention plan and provide evidence of data archival completion.
    • Schedule targeted refresher training sessions for clinician cohorts below proficiency thresholds.
    • Operational KPI dashboard
    • Deployment and migration validation
    • Decision on remediation closure
    • Root cause diagnosis for gaps
    • Major incidents and risk register
    • Retention and archival compliance
    • Open tickets and burn-down
    • Incumbent system decommission status
    • Capacity planning and storage sizing
    • Operational issues and defect review
    • Early adoption signals and usage patterns
    • Integration and backup health
    • Enhancement prioritization
    • Open issues and blockers
    • Agree corrective actions and timelines
    • Long-term enhancement roadmap
    • Training and proficiency update
    • Short-term enhancement priorities
    • Regulatory and validation posture
First-Party AI

1-2 minutes please — Your AI agent is working

First-Party AI™ can make mistakes. Always check important information.